Non-QM Originations Pace Post-Crisis Set for 2026 High
Bank of America Securities projects a new post-crisis peak for non-QM originations in 2026, driven by DSCR and invest...
What Is Glide Path In Target Date Funds
Glide path describes how a target date fund changes its asset mix as the target year approaches, balancing risk and growth for your retirement.
25,488 articles
Medicare Rules Retirees Need in 2026: Essential Guide
Turning 65 or planning 2026 retirement? This guide breaks down the medicare rules retirees need to understand to choo...
Ouster Director Sold Over 9,000 Shares: Investor Takeaways
An Ouster director recently disclosed an open-market sale of thousands of shares. This deep dive explains what such m...
Bunny’s Label Gave Justice: Gift Disclosure Lesson
A surprising gift disclosure involving a music label and a Supreme Court justice reveals the money-side of public tra...
Live Nation Execs Mocked Fans Spark Price Gouging Debate
A wave of unsealed court filings shines a harsh light on ticket prices and fees. This article translates the drama in...
Overlooked Income Minted Double as AMDY Surges on AMD Run
A little-known income ETF has doubled this year by selling covered calls on AMD, outperforming the broad market as th...
Bitcoin Price Prediction: Peter Brandt Eyes Gold Shift
Bitcoin faces renewed volatility as veteran trader Peter Brandt hints at moving BTC into gold, sparking a fresh debat...
Schd Dgro 2026: Numbers Point to a Surprising Winner
Early 2026 data shows SCHD pulling ahead of VYM and DGRO in total return and dividend growth, signaling a potential s...
Iradimed's Selling Steadily Plan: What It Signals Investors
Insider activity can be a clue about a company’s path, but the motives are varied. This article dissects iradimed's s...
Rate Adds Loan Officers From New American Funding Team
Rate expands its mortgage team by bringing 14 loan officers from New American Funding, aiming to boost production and...
Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
If You Bought SOXQ During March, You’re Up Triple-Digit Gains
A dramatic rebound in the Invesco PHLX Semiconductor ETF (SOXQ) has turned a March 2026 selloff into a triple-digit y...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status